The global isomalto-oligosaccharide (IMO) market size is expected to reach US$ 75.0 million in 2023. Sales of isomalto-oligosaccharides are set to accelerate with a CAGR of 7.6% and are estimated to be valued at US$ 156.9 million in 2033.
Attributes | Key Insights |
---|---|
Estimated Global Isomalto-oligosaccharide Market Size (2023E) | US$ 75.0 million |
Projected Isomalto-oligosaccharide Market Value (2033F) | US$ 156.9 million |
Value-based CAGR (2023 to 2033) | 7.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for functional food ingredients, including isomalto-oligosaccharides, is increasing significantly in response to consumer preference for personal health and well-being demand. Isomalto-oligosaccharides are generated from starch, categorized as prebiotics, and have a low glycaemic index.
Academic research and commercial advancements in the IMOs field are advancing due to rising consumer demand for low glycaemic foods. There is an increasing demand for natural, low-calorie sweeteners as emphasis on lowering sugar intake and battling obesity and diabetes is increasing on a global scale. Because of its unique capability to sweeten food products, isomalto-oligosaccharides have attracted a lot of research in this sector.
For consumers with diabetes or those attempting to maintain stable blood sugar levels, IMO is a good substitute for conventional sugar. This is because it provides a gentler sweetness without unfavorable blood sugar increases. Their adaptability further facilitates isomalto-oligosaccharides' market expansion.
IMOs are used in several bakery products, confectionery, dairy, and other food and beverage applications. Its functional properties, including the ability to improve texture and mouthfeel in several food items, have garnered interest from food manufacturers looking to enhance their product offerings.
Global isomalto-oligosaccharide sales grew at a CAGR of 5.8% from 2018 to 2022. Over the forecast period, the worldwide market for isomalto-oligosaccharides is set to progress at 7.6% CAGR.
Historical CAGR (2018 to 2022) | 5.8% |
---|---|
Forecast CAGR (2023 to 2033) | 7.6% |
As consumers become more health-conscious, there is a growing demand for healthier food and beverage options. IMO's low-calorie content and low glycaemic index make it an attractive alternative to traditional sugars and sweeteners.
Consumers are actively seeking products that allow them to reduce their sugar intake while still enjoying a sweet taste. This is expected to drive the worldwide demand for IMO-containing products.
The general consumer awareness of IMO and its health benefits is increasing. As people become informed about the positive impact of IMO on digestion and metabolism, they are more likely to seek out products that include this ingredient. This will likely fuel isomalto-oligosaccharide sales.
Countries like Japan and South Korea have shown significant adoption of isomalto-oligosaccharides, and the trend is expected to continue through 2033. This is attributable to growing interest in functional foods and the health benefits associated with IMO.
Isomalto-oligosaccharides became well-known as a calorie-efficient sweetener and substitute for regular sugars. Interest in IMOs is fueled by the growing emphasis on cutting calories and addressing health issues associated with excessive sugar intake.
The general trend toward health and well-being is opening doors for compounds such as isomalto-oligosaccharide. IMO is promoted as a prebiotic fiber and a helpful component that supports digestive health, thereby fueling its demand.
Isomalto-oligosaccharides are widely used in a variety of functional foods, such as protein bars, energy bars, and other items. With customers seeking more nutrient-dense options, demand for isomalto-oligosaccharides is set to rise rapidly.
Isomalto-oligosaccharides are adopted due to consumer desire for natural ingredients and clean-label products. IMO satisfies the clean label requirements because it is derived from natural sources like starch and appeals to consumers who want ingredient clarity.
Attributes | Key Factors |
---|---|
IMO Market Trends |
|
Growth Hindrances |
|
Upcoming Opportunities |
|
The table below highlights the anticipated growth of isomalto-oligosaccharide market across different countries. Among these, Australia is expected to remain a highly lucrative market for isomalto-oligosaccharide companies, exhibiting a CAGR of 9.9%. The United States and India are anticipated to follow with CAGRs of 6.6% and 7.5%, respectively.
Countries | CAGR |
---|---|
United States | 6.6% |
United Kingdom | 4.3% |
Germany | 3.5% |
India | 7.5% |
China | 6.5% |
Australia | 9.9% |
The United States isomalto-oligosaccharide market value is projected to increase from US$ 13.9 million in 2023 to US$ 26.4 million by 2033. Over the forecast period, sales of isomalto-oligosaccharides in the United States are expected to soar at a significant CAGR of 6.6%.
As consumers are becoming health-conscious and informed about the importance of gut health, there is a growing interest in incorporating prebiotics into their diets. In response to this trend, food and beverage manufacturers are seeking innovative ways to meet the rising demand for prebiotic products.
IMO's prebiotic properties make it a favorable choice for incorporation into a wide range of food items, including functional foods, snacks, beverages, and dietary supplements. IMO's ability to improve gut health while offering a mild sweetness and low-calorie content is making it an attractive ingredient for manufacturers looking to develop healthier and more functional food options.
China isomalto-oligosaccharide (IMO) market is expected to reach a valuation of around US$ 13.8 million by 2033. It will likely hold a prominent value share of 49.3% in the East Asia isomalto-oligosaccharide market.
With a growing middle-class population and increasing disposable incomes, demand for diverse and healthier food choices is on the rise. Consumers in China are becoming more health-conscious, seeking products that not only satiate their taste buds but also contribute to their overall well-being. IMO's unique properties align perfectly with this growing trend.
As a natural low-calorie sweetener with a low glycemic index, IMO serves as a healthier alternative to traditional sugars. It is ideal for health-conscious consumers looking to reduce their sugar intake.
The prebiotic characteristics of isomalto-oligosaccharides have gained attention as consumers recognize the importance of gut health and its impact on overall immunity and digestion. The versatility of isomalto-oligosaccharides further enhances its appeal in China.
Government's increasing focus on promoting a healthier lifestyle and supporting the development of functional foods and dietary supplements provides an encouraging regulatory environment for IMO's incorporation into several products. As health and wellness continue to be key considerations for consumers, the demand for prebiotic and healthier food options is expected to drive the adoption of IMO by food and beverage companies in China.
As per the latest analysis, India will emerge as a highly lucrative market for isomalto-oligosaccharide manufacturers, exhibiting a CAGR of 7.5% through 2033. This is attributable to rising prevalence of obesity and diabetes and increasing interest in prebiotic ingredients.
In India, customers are apt to accept new and inventive culinary items. Isomalto-oligosaccharides are introduced by manufacturers into a range of food and beverage applications, such as bread goods, confections, and snacks.
Rising cases of obesity and diabetes are prompting people across India to opt for low-calorie foods. To cater to this demand, top food manufacturing companies in the country are utilizing low-calorie sweeteners like isomalto-oligosaccharides. This will continue to fuel sales.
Growing awareness about the advantages of isomalto-oligosaccharides, such as their low-calorie content and function in gut health, is expected to drive demand. Similarly, promotional strategies emphasizing functional and health-related factors can boost sales in India.
Australia isomalto-oligosaccharide market is expected to surge at a CAGR of 9.9% through 2033. Products that support digestive health are becoming popular worldwide, and Australia is no exception. As a prebiotic fiber, isomalto-oligosaccharides are used in a range of goods in Australia.
Clean-label items with natural and little processed components are frequently preferred by customers in Australia. Isomalto-oligosaccharides fit in nicely with this inclination as they are marketed as a natural source of fiber and sweetness.
Sales of isomalto-oligosaccharides in the United Kingdom are predicted to rise at a CAGR of 4.3%. This is attributable to rising health awareness and growing need for low-calorie sweeteners.
Health and wellbeing are highly valued in the United Kingdom. Customers in the country are increasingly looking for items that provide useful health advantages. Given their prebiotic qualities and potential as a low-calorie sweetener, isomalto-oligosaccharides may be a good fit for these consumer desires.
In the United Kingdom, there could be an increasing need for IMO sweeteners due to the high rate of diabetes and widespread knowledge of the negative effects of consuming too much sugar. As a low-calorie alternative, isomalto-oligosaccharides could be accepted in this market.
The market for functional foods and drinks is well-established in the United Kingdom. Because of its valuable qualities as a prebiotic fiber, isomalto-oligosaccharides can be added to a variety of products that are meant to improve general health and digestive health.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The below section shows the liquid IMO segment dominating the worldwide isomalto-oligosaccharide industry. It is expected to hold a market share of 68.5% by 2033. Based on end use, the dietary supplements segment is set to account for a revenue share of 33.2% by 2033.
Form | Liquid |
---|---|
Market Share (2033) | 68.5% |
Based on form, demand is expected to remain high for liquid isomalto-oligosaccharides during the assessment period. The target segment is expected to total US$ 99.9 million by 2033, holding a market share of around 68.5%.
Liquid isomalto-oligosaccharide is recognized as a highly purified proliferation factor of the Bifidus. IMOs have gained popularity as an alternative sweetener to traditional sugars due to their low-calorie content and minimal impact on blood sugar levels.
Liquid isomalto-oligosaccharides are particularly appealing to individuals looking to reduce their sugar intake, manage their weight, or regulate blood glucose levels. This has resulted in a growing market for products labeled as 'low sugar' or 'sugar-free', where liquid isomalto oligosaccharide finds extensive use as a sugar substitute in several food and beverage applications.
Liquid isomalto oligosaccharide is becoming an attractive ingredient for several food formulations, including bakery products, beverages, dairy, and confectionery. This is because of its functional properties, such as its ability to enhance mouthfeel and provide a mild sweetness.
The optimization of enzymatic conversion methods and the development of efficient purification techniques have increased the yield and reduced production costs. This is making it more economically viable for manufacturers to produce liquid IMO in larger quantities.
End-use Application | Dietary Supplements |
---|---|
Market Share (2033) | 33.2% |
The dietary supplement segment is estimated to dominate the market with a share of 33.2% by 2033. The target segment is projected to reach a valuation of US$ 48.4 million by 2033. This is attributable to rising usage of IMOs in dietary supplements due to their multiple health benefits.
Isomalto-oligosaccharide, classified as a functional dietary fiber, is widely used in functional foods and dietary supplements. This is due to its ability to promote gut health, reduce cholesterol levels, and support the immune system.
Isomalto-oligosaccharides (IMO) are used as a functional food and prebiotic fiber sweetener. They have favorable gastrointestinal benefits in males, such as increasing defecation frequency and as a prebiotic to increase the growth of fecal bifidobacteria.
The continuous advancements in technology and production processes have significantly improved the quality and cost-effectiveness of isomalto-oligosaccharides. As a result, several companies are entering the market, leading to increased competition and product innovation.
Collaborations between food manufacturers and IMO suppliers have become prevalent, driving the development of novel products that cater to evolving consumer preferences. Evidence-based practice and increasing health awareness are empowering the niche IMO market. The increasing number of potential health claims based on applications in several types of food is significantly tied to the rise of IMO commercialization.
A variety of IMO preparations are created and marketed, with two of the most well-known brands being IMO-900® and VitaFiberTM IMO. A large number of patents for IMOs production technologies have been submitted, and the number is expanding, particularly in Asian, United States, European, Australian-New Zealand, and Canadian markets.
Companies are utilizing IMOs to create novel ingredients or solutions. For instance, Lissenare, a new ingredient made from natural isomalto-oligosaccharides, was developed by NAGASE & Co., Ltd. in December 2021.
Attribute | Details |
---|---|
Estimated Isomalto-oligosaccharide Market Size (2023) | US$ 75.0 million |
Projected Isomalto-oligosaccharide Market Value (2033) | US$ 156.9 million |
Estimated Growth Rate (2023 to 2033) | 7.6% CAGR |
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | Volume (MT) and Value (US$ million) |
Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East and Africa |
Key Countries Covered | Canada, United States, Mexico, Brazil, Chile, Peru, Argentina, Germany, France, Italy, Spain, United Kingdom, Netherlands, Belgium, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Central Africa, and others |
Key Market Segments Covered | Form, Source, End-use Application, and Region |
Key Companies Profiled | Dancheng Caixin Sugar Industry Co., Ltd.; Guangzhou Shuangqiao Co., Ltd.; Luzhou Bio-Chem Technology Ltd.; Mie-karyo Co., Ltd.; New Francisco Biotechnology Corporation (NFBC); Nihon Shokuhin Kako Co., Ltd.; Shandong Tianmei Biotech Co., Ltd.; Baolingbao Biology Co., Ltd.; BioNeutra North America Inc.; COFCO Rongshi Biotechnology Co., Ltd.; Shandong Bailong Chuangyuan Bio-Tech CO. LTD.; Baolingbao Biology Co.; Fingres |
The isomalto-oligosaccharide market size is estimated to reach US$ 75.0 million in 2023.
Isomalto-oligosaccharide demand is set to grow at 7.6% through 2033.
The market size is expected to reach US$ 156.9 million by 2033.
Europe is expected to have a market share of 26% in 2023.
Isomalto-oligosaccharides are mostly used in food products and dietary supplements.
Isomalto-oligosaccharides are commercially made from starch.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Dynamics 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends By Region 3.5. Product Claims & Nutritional Information Scan by Buyers 3.6. Macro-Economic Factors 3.7. Forecast Factors – Relevance & Impact 4. Global Market - Pricing Analysis 4.1. Price Point Assessment by Region 4.1.1. Manufacturer-Level Pricing 4.1.2. Distributor Level Pricing 4.2. Price Point Assessment By Form 4.3. Price Forecast till 2033 5. Value Chain Analysis 5.1. Operating margins at each node of the supply chain 5.2. List of Active Market Participants 5.2.1. Product Manufacturers 6. Global Market Demand (in Value (US$ million) and Volume (MT) Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Value (US$ million) and Volume (MT) Analysis, 2018 to 2022 6.2. Current and Future Market Value (US$ million) and Volume (MT) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Form 7.1. Historical Market Size (US$ million) and Volume (MT) Analysis By Form, 2018 to 2022 7.2. Current and Future Market Size (US$ million) and Volume (MT) Analysis and Forecast By Form, 2023 to 2033 7.2.1. Liquid 7.2.2. Powder 7.3. Market Attractiveness Analysis By Form 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Source 8.1. Historical Market Size (US$ million) and Volume (MT) Analysis By Source, 2018 to 2022 8.2. Current and Future Market Size (US$ million) and Volume (MT) Analysis and Forecast By Source, 2023 to 2033 8.2.1. Corn 8.2.2. Wheat 8.2.3. Potato 8.2.4. Tapioca 8.2.5. Others (Oats, Rice) 8.3. Market Attractiveness Analysis By Source 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use Application 9.1. Historical Market Size (US$ million) and Volume (MT) Analysis By End-use Application, 2018 to 2022 9.2. Current and Future Market Size (US$ million) and Volume (MT) Analysis and Forecast By End-use Application, 2023 to 2033 9.2.1. Food & Beverages 9.2.1.1. Functional Food 9.2.1.2. Dairy Products 9.2.1.3. Infant Formula 9.2.2. Dietary Supplements 9.2.2.1. Weight Loss 9.2.2.2. Sports Nutrition 9.2.2.3. General Well-Being 9.2.3. Animal Feed Additives 9.2.3.1. Poultry 9.2.3.2. Swine 9.2.3.3. Cattle 9.3. Market Attractiveness Analysis By End-use Application 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 10.1. Historical Market Size (US$ million) and Volume (MT) Analysis By Region, 2018 to 2022 10.2. Current Market Size (US$ million) and Volume (MT) Analysis and Forecast By Region, 2023 to 2033 10.2.1. North America 10.2.2. Latin America 10.2.3. Europe 10.2.4. East Asia 10.2.5. South Asia 10.2.6. Oceania 10.2.7. Middle East & Africa 10.3. Market Attractiveness Analysis By Region 10.4. Key Takeaways 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. United States 11.2.1.2. Canada 11.2.2. By Form 11.2.3. By Source 11.2.4. By End-use Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Form 11.3.3. By Source 11.3.4. By End-use Application 11.4. Key Takeaways 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Argentina 12.2.1.4. Rest of Latin America 12.2.2. By Form 12.2.3. By Source 12.2.4. By End-use Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Form 12.3.3. By Source 12.3.4. By End-use Application 12.4. Key Takeaways 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. United Kingdom 13.2.1.3. France 13.2.1.4. Italy 13.2.1.5. Spain 13.2.1.6. BENELUX 13.2.1.7. Nordic 13.2.1.8. Russia 13.2.1.9. Poland 13.2.1.10. Rest of Europe 13.2.2. By Form 13.2.3. By Source 13.2.4. By End-use Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Form 13.3.3. By Source 13.3.4. By End-use Application 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Form 14.2.3. By Source 14.2.4. By End-use Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Form 14.3.3. By Source 14.3.4. By End-use Application 14.4. Key Takeaways 15. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. India 15.2.1.2. Thailand 15.2.1.3. Malaysia 15.2.1.4. Indonesia 15.2.1.5. Vietnam 15.2.1.6. Philippines 15.2.1.7. Singapore 15.2.1.8. Rest of South Asia 15.2.2. By Form 15.2.3. By Source 15.2.4. By End-use Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Form 15.3.3. By Source 15.3.4. By End-use Application 15.4. Key Takeaways 16. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. Australia 16.2.1.2. New Zealand 16.2.2. By Form 16.2.3. By Source 16.2.4. By End-use Application 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Form 16.3.3. By Source 16.3.4. By End-use Application 16.4. Key Takeaways 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 17.2. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 17.2.1. By Country 17.2.1.1. GCC Countries 17.2.1.2. Turkiye 17.2.1.3. Egypt 17.2.1.4. South Africa 17.2.1.5. Rest of Middle East and Africa 17.2.2. By Form 17.2.3. By Source 17.2.4. By End-use Application 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.2. By Form 17.3.3. By Source 17.3.4. By End-use Application 17.4. Key Takeaways 18. Country-level Market Analysis 18.1. United States Market Analysis 18.1.1. By Form 18.1.2. By Source 18.1.3. By End-use Application 18.2. Canada Market Analysis 18.2.1. By Form 18.2.2. By Source 18.2.3. By End-use Application 18.3. Brazil Market Analysis 18.3.1. By Form 18.3.2. By Source 18.3.3. By End-use Application 18.4. Mexico Market Analysis 18.4.1. By Form 18.4.2. By Source 18.4.3. By End-use Application 18.5. Argentina Market Analysis 18.5.1. By Form 18.5.2. By Source 18.5.3. By End-use Application 18.6. Germany Market Analysis 18.6.1. By Form 18.6.2. By Source 18.6.3. By End-use Application 18.7. United Kingdom Market Analysis 18.7.1. By Form 18.7.2. By Source 18.7.3. By End-use Application 18.8. France Market Analysis 18.8.1. By Form 18.8.2. By Source 18.8.3. By End-use Application 18.9. Italy Market Analysis 18.9.1. By Form 18.9.2. By Source 18.9.3. By End-use Application 18.10. Spain Market Analysis 18.10.1. By Form 18.10.2. By Source 18.10.3. By End-use Application 18.11. BENELUX Market Analysis 18.11.1. By Form 18.11.2. By Source 18.11.3. By End-use Application 18.12. Nordic Market Analysis 18.12.1. By Form 18.12.2. By Source 18.12.3. By End-use Application 18.13. Russia Market Analysis 18.13.1. By Form 18.13.2. By Source 18.13.3. By End-use Application 18.14. Poland Market Analysis 18.14.1. By Form 18.14.2. By Source 18.14.3. By End-use Application 18.15. China Market Analysis 18.15.1. By Form 18.15.2. By Source 18.15.3. By End-use Application 18.16. Japan Market Analysis 18.16.1. By Form 18.16.2. By Source 18.16.3. By End-use Application 18.17. India Market Analysis 18.17.1. By Form 18.17.2. By Source 18.17.3. By End-use Application 18.18. Thailand Market Analysis 18.18.1. By Form 18.18.2. By Source 18.18.3. By End-use Application 18.19. Malaysia Market Analysis 18.19.1. By Form 18.19.2. By Source 18.19.3. By End-use Application 18.20. Indonesia Market Analysis 18.20.1. By Form 18.20.2. By Source 18.20.3. By End-use Application 18.21. Vietnam Market Analysis 18.21.1. By Form 18.21.2. By Source 18.21.3. By End-use Application 18.22. Philippines Market Analysis 18.22.1. By Form 18.22.2. By Source 18.22.3. By End-use Application 18.23. Singapore Market Analysis 18.23.1. By Form 18.23.2. By Source 18.23.3. By End-use Application 18.24. Australia Market Analysis 18.24.1. By Form 18.24.2. By Source 18.24.3. By End-use Application 18.25. New Zealand Market Analysis 18.25.1. By Form 18.25.2. By Source 18.25.3. By End-use Application 18.26. Turkiye Market Analysis 18.26.1. By Form 18.26.2. By Source 18.26.3. By End-use Application 18.27. GCC Countries Market Analysis 18.27.1. By Form 18.27.2. By Source 18.27.3. By End-use Application 18.28. Central Africa Market Analysis 18.28.1. By Form 18.28.2. By Source 18.28.3. By End-use Application 18.29. South Africa Market Analysis 18.29.1. By Form 18.29.2. By Source 18.29.3. By End-use Application 19. Market Structure Analysis 19.1. Global Market Competition - a Dashboard View 19.2. Global Market Structure Analysis 19.3. Global Market Company Share Analysis 19.3.1. For Tier 1 Market Players, 2023 19.3.2. Company Market Share Analysis of Top Players, By Region 19.4. Key Participants Market Presence (Intensity Mapping) by Region 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Dancheng Caixin Sugar Industry Co., Ltd. 20.3.1.1. Product Portfolio 20.3.1.2. Revenue by Market Segments 20.3.1.3. Sales Footprint 20.3.1.4. Strategy Overview 20.3.2. Guangzhou Shuangqiao Co., Ltd. 20.3.3. Luzhou Bio-Chem Technology Ltd. 20.3.4. Mie-karyo Co., Ltd. 20.3.5. New Francisco Biotechnology Corporation (NFBC) 20.3.6. Nihon Shokuhin Kako Co., Ltd. 20.3.7. Shandong Tianmei Biotech Co., Ltd. 20.3.8. Baolingbao Biology Co., Ltd. 20.3.9. BioNeutra North America Inc. 20.3.10. COFCO Rongshi Biotechnology Co., Ltd. 20.3.11. Other Players (On Additional Requests) 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Food and Beverage Insights
View Reports